Harvey Carter, MD
Ophthalmology · Dallas, TXNPI 1164430187
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,683 of the $9,916 with a category attached, or 87.6%. 19 manufacturers reported payments, led by Biotissue Holdings Inc. at 30.8% of the total.
Across 232 payments — averaging $42.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$3K
- Alcon$2K
- Lensar, Inc.$2K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Glaukos Corporation$708
- Bausch & Lomb Americas Inc.$366
- plus $810 from 13 others
Across 6 payments — averaging $2911.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$17K
What the payments were for
- Travel & lodging$1,23412%
- Food & beverage$8,68388%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 52 | $3,050 |
| Alcon | 101 | $2,066 |
| Lensar, Inc. | 10 | $1,816 |
| Johnson & Johnson Surgical Vision, Inc. | 21 | $1,100 |
| Glaukos Corporation | 9 | $708 |
| Bausch & Lomb Americas Inc. | 13 | $366 |
| Rayner Intraocular Lenses Limited | 4 | $137 |
| Tearlab Corp | 3 | $133 |
| Carl Zeiss Meditec USA, Inc. | 1 | $131 |
| Mallinckrodt Hospital Products Inc. | 4 | $92 |
| Novartis | 3 | $71 |
| Eyevance Pharmaceuticals LLC | 3 | $51 |
| AbbVie | 1 | $50 |
| Oyster Point Pharma, Inc. | 2 | $47 |
| Eyepoint US, Inc. | 1 | $24 |
| Dompe US, Inc. | 1 | $23 |
| Thea Pharma Inc. | 1 | $19 |
| Sight Sciences, Inc. | 1 | $16 |
| Tarsus Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$2,006
- AmnioGraft$2,006
- LENSAR LASER SYSTEM$1,521
- Clareon$660
- AcrySof IQ PanOptix$273
- Catalys Laser System$248
- Clareon PanOptix Pro$144
- Wavelight$133
- VisuMax$131
- ARGOS$126
- VERITAS Vision System$125
- PanOptix$125
- STAR S4 IR$101
- Tecnis Simplicity$101
- IDESIGN RS$101
- CATALYS SYSTEM$101
- TearLab Osmolarity System$101
How this compares
$9,916 in reported general payments places this provider in the 85th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 169 | $8,994 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 14 | $2,139 |
| Ketorolac Tromethamine | 40 | $1,535 |
| Ofloxacin | 92 | $1,510 |
| Latanoprost | 87 | $587 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $119 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $55 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Dallas
- Oluwatosin SmithDallas$1.5M
- Davinder GroverDallas$705K
- Ashkan AbbeyDallas$559K
- Karl CsakyDallas$426K
- Jeffrey WhitmanDallas$190K
- Robert WangDallas$144K
- Arvind NeelakantanDallas$90K
- Michael SingerSan Antonio$1.8M
- Charles WykoffBellaire$1.5M
- John MichelettiHouston$916K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.